CD4+ T cells, human cytomegalovirus and end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 5, 2011, Pages 1467-1470

  Wang, Eddie C Y ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

CD4+ T cells; cytotoxic; end stage renal disease; HCMV

Indexed keywords

ANTIGEN SPECIFICITY; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOMODULATION; KIDNEY FAILURE; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS LOAD;

CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79955575455     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr167     Document Type: Review

References (42)

1. Janeway CA Jr. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 1992; 10: 645-674
2. Zinkernagel RM, Doherty PC Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974; 248: 701-702
3. Szabo SJ, Kim ST, Costa GL et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100: 655-669
4. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89: 587-596 (Pubitemid 27511769)
5. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132 (Pubitemid 41541790)
6. Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121-1133 (Pubitemid 44380299)
7. Liang SC, Tan XY, Luxenberg DP et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression ofantimicrobial peptides. J Exp Med 2006; 203: 2271-2279 (Pubitemid 44498362)
8. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141 (Pubitemid 41541791)
9. Fontenot JD, Gavin MA, Rudensky AY Foxp3 programs the devel-opment and function of CD4+CD25+ regulatory T cells. Nat Immu-nol 2003; 4: 330-336 (Pubitemid 36432314)
10. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell develop-ment by the transcription factor Foxp3. Science 2003; 299: 1057-1061 (Pubitemid 36222930)
11. Khattri R, Cox T, Yasayko SA et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 337-342 (Pubitemid 36432315)
12. Dardalhon V, Awasthi A, Kwon H et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008; 9: 1347-1355
13. Veldhoen M, Uyttenhove C, van Snick J et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and pro-motes an interleukin 9-producing subset. Nat Immunol 2008; 9: 1341-1346
14. Trifari S, Kaplan CD, Tran EH et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009; 10: 864-871
15. Kurane I, Meager A, Ennis FA. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma pro-duction, and cytotoxic activity. J Exp Med 1989; 170: 763-775 (Pubitemid 19226663)
16. van Binnendijk RS, Poelen MC, de Vries P et al. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. J Immunol 1989; 142: 2847-2854 (Pubitemid 19114905)
17. Bourgault I, Gomez A, Gomard E et al. A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regu-larly develops in uncloned human antiviral cell lines. J Immunol 1989; 142: 252-256 (Pubitemid 19034750)
18. Torpey DJ 3rd, Lindsley MD, Rinaldo CR Jr. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes. J Immunol 1989; 142: 1325-1332 (Pubitemid 19067508)
19. Hopkins JI, Fiander AN, Evans AS et al. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J Med Virol 1996; 49: 124-131 (Pubitemid 26195856)
20. Zal B, Kaski JC, Arno G et al. Heat-shock protein 60-reactive CD4 +CD28null T cells in patients with acute coronary syndromes. Circulation 2004; 109: 1230-1235 (Pubitemid 38372781)
21. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004; 4: 648-655 (Pubitemid 39025050)
22. Casazza JP, Betts MR, Price DA et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 2006; 203: 2865-2877 (Pubitemid 46026164)
23. Sallusto F, Lenig D, Forster R et al. Two subsets ofmemory T lympho-cytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712
24. Sylwester AW, Mitchell BL, Edgar JB et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202: 673-685 (Pubitemid 41248418)
25. Wang EC, Moss PA, Frodsham P et al. CD8highCD57+ T lympho-cytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol 1995; 155: 5046-5056 (Pubitemid 3010847)
26. Khan N, Shariff N, Cobbold M et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. JImmunol 2002; 169: 1984-1992 (Pubitemid 34857662)
27. Yadav A, Jha V CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis. Nephrol Dial Transplant 2011; 26: 1689-1694
28. Betjes MG, Huisman M, Weimar W et al. Expansion of cytolytic CD4+CD28-T cells in end-stage renal disease. Kidney Int 2008; 74: 760-767
29. Soderberg-Naucler C, Fish KN, Nelson JA. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus- permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997; 100: 3154-3163 (Pubitemid 28022854)
30. Reeves MB, MacAry PA, Lehner PJ et al. Latency, chromatin remod-eling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 2005; 102: 4140-4145 (Pubitemid 40388569)
31. Sinclair J. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J Clin Virol 2008; 41: 180-185
32. Rahbar A, Bostrom L, Lagerstedt U et al. Evidence of active cyto-megalovirus infection and increased production of IL-6 in tissue spe-cimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis 2003; 9: 154-161 (Pubitemid 36592445)
33. Grattan MT, Moreno-Cabral CE, Starnes VA et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atheroscler-osis. JAMA 1989; 261: 3561-3566 (Pubitemid 19155945)
34. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
35. Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293: 1737-1745
36. Liuzzo G, Goronzy JJ, Yang H et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-2888 (Pubitemid 30415876)
37. Sato K, Niessner A, Kopecky SL et al. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atheroscler-otic plaque. JExp Med 2006; 203: 239-250 (Pubitemid 43139661)
38. Sedger LM, Shows DM, Blanton RA et al. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 1999; 163: 920-926 (Pubitemid 29328103)
39. Betjes MG, Litjens NH, Zietse R. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with ath-erosclerotic disease. Nephrol Dial Transplant 2007; 22: 3298-3303 (Pubitemid 350202544)
40. Roberts GW, Baird D, Gallagher K et al. Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis. JAm Soc Nephrol 2009; 20: 1895-1900
41. Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 2003; 362: 903-908 (Pubitemid 37130102)
42. Yach D, Hawkes C, Gould CL et al. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004; 291: 2616-2622 (Pubitemid 38702780)